Cell systems最新文献

Protein language models (PLMs), such as the highly successful ESM-2, have proven particularly effective. However, language models designed for RNA continue to face challenges. A key question is as follows: can the information derived from PLMs be harnessed and transferred to RNA? To investigate this, a model termed ProtRNA has been developed by a cross-modality transfer learning strategy for addressing the challenges posed by RNA's limited and less conserved sequences. By leveraging the evolutionary and physicochemical information encoded in protein sequences, the ESM-2 model is adapted to processing "low-resource" RNA sequence data. The results show comparable or superior performance in various RNA downstream tasks, with only 1/8 the trainable parameters and 1/6 the training data employed by the primary reference baseline RNA language model. This approach highlights the potential of cross-modality transfer learning in biological language models.

Although antibody sequences are highly diverse, they are constrained by requirements for expression and limited off-target reactivity. Describing which sequences violate such constraints has proven to be difficult. Here, we introduce a machine-learning framework to leverage a previously underutilized source of data for this problem. We use human single-cell sequencing data to find instances of allelic inclusion, a rare event where B cells express two different antibody light chains as mRNA. Previous studies suggest that one of these chains is either autoreactive or non-expressing as protein. We train machine-learning models to identify abnormal sequences associated with allelic inclusion. The resulting models generalize to predict antibody properties including polyreactivity, surface expression, and mutation usage, outperforming methods that do not use allelic inclusion data. We also investigate similar selection forces on the heavy chain in mice and observe that surrogate light-chain pairing has a large impact on heavy-chain diversity.

Understanding how the microbiota produces regulatory metabolites is of significance for cancer and cancer therapy. Using a host-microbe-drug-nutrient 4-way screening approach, we evaluated the role of nutrition at the molecular level in the context of 5-fluorouracil toxicity. Notably, our screens identified the metabolite 2-methylisocitrate, which was found to be produced and enriched in human tumor-associated microbiota. 2-methylisocitrate exhibits anti-proliferative properties across genetically and tissue-diverse cancer cell lines, three-dimensional (3D) spheroids, and an in vivo Drosophila gut tumor model, where it reduced tumor dissemination and increased survival. Chemical landscape interaction screens identified drug-metabolite signatures and highlighted the synergy between 5-fluorouracil and 2-methylisocitrate. Multi-omic analyses revealed that 2-methylisocitrate acts via multiple cellular pathways linking metabolism and DNA damage to regulate chemotherapy. Finally, we converted 2-methylisocitrate into its trimethyl ester, thereby enhancing its potency. This work highlights the great impact of microbiome-derived metabolites on tumor proliferation and their potential as promising co-adjuvants for cancer treatment.

Spatial transcriptomics allows for the measurement of gene expression within the native tissue context. However, despite technological advancements, computational methods to link cell states with their microenvironment and compare these relationships across samples and conditions remain limited. To address this, we introduce Tissue Motif-Based Spatial Inference across Conditions (TissueMosaic), a self-supervised convolutional neural network designed to discover and represent tissue architectural motifs from multi-sample spatial transcriptomic datasets. TissueMosaic further links these motifs to gene expression, enabling the study of how changes in tissue structure impact cell-intrinsic function. TissueMosaic increases the signal-to-noise ratio of spatial differential expression analysis through a motif enrichment strategy, resulting in more reliable detection of genes that covary with tissue structure changes. Here, we demonstrate that TissueMosaic learns representations that outperform neighborhood cell-type composition baselines and existing methods on downstream tasks. These findings underscore the potential of self-supervised learning to advance spatial transcriptomics discovery.

Identifying cell types in highly multiplexed images is essential for understanding tissue spatial organization. Current cell-type annotation methods often rely on extensive reference images and manual adjustments. In this work, we present a tool, the Robust Image-Based Cell Annotator (RIBCA), that enables accurate, automated, unbiased, and fine-grained cell-type annotation for images with a wide range of antibody panels without requiring additional model training or human intervention. Our tool has successfully annotated over 3 million cells, revealing the spatial organization of various cell types across more than 40 different human tissues. It is open source and features a modular design, allowing for easy extension to additional cell types.

Microbial colonization is shaped by a complex network of interactions that influence both commensals and pathogens, including the public-health threat Clostridioides difficile. In this issue of Cell Systems, Carr et al. present a community-scale modeling framework for predicting colonization and metabolism, offering new insights into C. difficile infection.

Recent advances in generative modeling enable efficient sampling of protein structures, but their tendency to optimize for designability imposes a bias toward idealized structures at the expense of loops and other complex structural motifs that are critical for function. We introduce SHAPES (structural and hierarchical assessment of proteins with embedding similarity) to evaluate five state-of-the-art generative models of protein structures. Using structural embeddings across multiple structural hierarchies, ranging from local geometries to global protein architectures, we reveal substantial undersampling of the observed protein structure space by these models. We use Fréchet protein distance (FPD) to quantify distributional coverage. Different models are distinct in their coverage behavior across different sampling noise scales and temperatures. The frequency of tertiary motifs (TERMs) further supports the observations. More robust sequence design and structure prediction methods are likely crucial in guiding the development of models with improved coverage of the designable protein space. A record of this paper's transparent peer review process is included in the supplemental information.

Comprehensively mapping all targets of a T cell receptor (TCR) is important for predicting pathogenic escape and off-target effects of TCR therapies. However, this mapping has been challenging due to lack of unbiased benchmarking datasets and computational methods sensitive to small-peptide mutations. To address this, we curated the benchmark for activation of T cells with cross-reactive avidity for epitopes (BATCAVE) database, encompassing near-complete single-amino-acid mutational assays, centered around 25 immunogenic epitopes, across both major histocompatibility complex classes, against 151 human and mouse TCRs, containing 22,000+ TCR-peptide pairs in total. We then introduce Bayesian inference of activation of TCR by mutant antigens (BATMAN), an interpretable Bayesian model, trained on BATCAVE, for predicting the peptides that activate a TCR, and an active learning extension, which efficiently maps targets of a novel TCR by selecting a few peptides to assay. We show that BATMAN outperforms existing methods, reveals structural and biochemical predictors of TCR-peptide interactions, and can predict polyclonal T cell responses and TCR targets with high sequence dissimilarity. A record of this paper's transparent peer review process is included in the supplemental information.

Tumor invasion constitutes a multifaceted process encompassing collective cellular migration and dynamic cell-fate transitions. Although these aspects have been studied separately by physicists and biologists, their spatiotemporal coupling remains unclear. To bridge this gap, we introduce a tumor-adipose assembloid model that facilitates live tracking and temporal analysis of cancer cells and adipocytes. The tumor assembloids manifest two discrete phases of morphogenic behavior, delineated by the reprogramming of adipocytes. In the initial phase, the biophysical interactions between cancer cells and adipocytes can be modeled as contact between viscoelastic drops. This interaction precedes the adipocytes' dedifferentiation and subsequent myofibrogenic reprogramming. The emergence of adipocyte-derived myofibroblasts instigates assembloid invasion through the mechanical remodeling of surrounding collagen networks. Our findings unveil a paradigm shift in understanding the evolutionary dynamics of heterotypic multicellular systems, wherein cell-fate transitions act as catalytic events that initiate serial patterns of collective morphogenesis via alterations in extracellular biophysical interactions.

Microbiomes often show similar functional profiles despite highly variable taxonomic compositions, a phenomenon attributed to "functional redundancy" and presumed selection for functional traits. However, this link between functional variability and selection remains vaguely defined. We demonstrate that reduced functional variability can arise from statistical averaging when aggregating taxonomic abundances and does not necessarily imply selection. We introduce an empirical null model that accounts for this statistical averaging effect. Applying this model to microbial communities from bromeliad foliage, we find no evidence of functional selection. In contrast, soil and human gut communities grown in vitro exhibit selection for metabolic functions. We also find that correlations between functions and taxonomic abundances can produce misleading signals of selection. Using an extended null model, we show that apparent functional selection in Human Microbiome Project data is artifactual. Our framework clarifies the conditions under which functional selection can be meaningfully inferred from microbiome data.